#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant oligodendroglioma Non-Hodgkin's lymphoma refractory Postprandial hypoglycaemia Autoimmune demyelinating disease Myasthenia gravis Central nervous system lymphoma Thalassaemia beta Enteritis Oesophageal atresia Adult T-cell lymphoma/leukaemia refractory Ovarian cancer stage III Inflammatory myofibroblastic tumour Chronic hepatitis B Plasma cell myeloma refractory Skin angiosarcoma More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia – Basic Information Small intestine leiomyosarcoma – Life with Disease Adrenogenital syndrome Erdheim-Chester disease MELAS syndrome – Diagnostics Phenylketonuria – Trials in Disease Noonan syndrome – Basic Information Hairy cell leukaemia recurrent – Basic Information Myxofibrosarcoma – Trials in Disease Proteus syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Selgantolimod Methylprednisolone Acetate Tegafur Dacarbazine CILOSTAZOL Methionine Ponsegromab Tapderimotide Adrenaline Tartrate Ph. Eur. Dalteparin Sodium HALOBETASOL PROPIONATE Etanercept Regn7257 Rocatinlimab Filgrastim Oxycodone Hydrochloride Mva-Hbvac Vosilasarm Pegunigalsidase Alfa Cemiplimab More therapies…

    Learn about Your Condition

    Peripheral spondyloarthritis Small intestine adenocarcinoma Lymphangioleiomyomatosis Transient ischaemic attack Gastrointestinal disorder Bone marrow disorder Wiskott-Aldrich syndrome Genitourinary tract neoplasm Migraine without aura Mucopolysaccharidosis Arthralgia Mite allergy Food allergy Venous thrombosis limb Enteritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Using Furosemide and Hydrochlorothiazide for Treating Patients with Acute Heart Failure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure acute
    Investigated Drugs:
    • Furosemide
    • Hydrochlorothiazide
    Spain

  • Study on the Effects of Inhaled Furosemide and Oral Levodropropizine on Breathing Difficulty in Patients with Advanced Lung Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • Furosemide
    • Levodropropizine
    • Sodium Chloride
    Czechia

  • Study of cangrelor with mechanical thrombectomy in patients with acute ischemic stroke selected by perfusion imaging

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Thrombectomy
    • Ischaemic stroke
    Investigated Drugs:
    • Cangrelor Tetrasodium
    France

  • Study Comparing [68Ga]Ga-PentixaFor PET/CT and AVS for Diagnosing Primary Aldosteronism in Patients with Hypertension

    Recruiting

    4 1 1
    Investigated Diseases:
    • Primary hyperaldosteronism
    Investigated Drugs:
    • Pentixafor
    • Gallium (68Ga)
    The Netherlands

  • Long-Term Safety Study of Dabrafenib Mesylate and Trametinib Dimethyl Sulfoxide for Patients Benefiting from Previous Treatment in Multiple Indications

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Trametinib
    • Dabrafenib Mesylate
    Austria Czechia Denmark France Germany Hungary +2

  • Study for Children and Adolescents with Recurrent or Relapsed Solid Tumors Using Lutetium (177Lu) Oxodotreotide and Olaparib

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    • Olaparib
    Spain
Previous Page
1 … 329 330 331 332 333 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!